Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel - Small, David S; Farid, Nagy A; Payne, Christopher D; Weerakkody, Govinda J; Li, Ying G; Brandt, John T; Salazar, Daniel E; Winters, Kenneth J (Journal of clinical pharmacology, 2008)
Keywords: 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects; 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology; Adenosine Diphosphate - blood; Adolescent; Adult; Aged; Area Under Curve; Biological Availability; Cross-Over Studies; Drug Interactions; Female; Humans; Lansoprazole; Male; Middle Aged; Piperazines - adverse effects; Piperazines - pharmacokinetics; Platelet Aggregation - drug effects; Platelet Aggregation Inhibitors - adverse effects; Platelet Aggregation Inhibitors - pharmacokinetics; Prasugrel Hydrochloride; Proton Pump Inhibitors - adverse effects; Proton Pump Inhibitors - pharmacology; Thiophenes - adverse effects; Thiophenes - pharmacokinetics; Ticlopidine - adverse effects; Ticlopidine - analogs & derivatives; Ticlopidine - pharmacokinetics